Literature DB >> 12782660

SARS coronavirus: a new challenge for prevention and therapy.

Kathryn V Holmes1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12782660      PMCID： PMC156116          DOI： 10.1172/JCI18819

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  30 in total

1.  Preliminary clinical description of severe acute respiratory syndrome.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-03-28       Impact factor: 17.586

2.  Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.

Authors:  Bruce D Zelus; Jeanne H Schickli; Dianna M Blau; Susan R Weiss; Kathryn V Holmes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Receptor-induced conformational changes of murine coronavirus spike protein.

Authors:  Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Conservation of substrate specificities among coronavirus main proteases.

Authors:  Annette Hegyi; John Ziebuhr
Journal:  J Gen Virol       Date:  2002-03       Impact factor: 3.891

5.  Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report.

Authors:  Moira Chan-Yeung; W C Yu
Journal:  BMJ       Date:  2003-04-19

6.  Mucosal and systemic isotype-specific antibody responses and protection in conventional pigs exposed to virulent or attenuated porcine epidemic diarrhoea virus.

Authors:  M L de Arriba; A Carvajal; J Pozo; P Rubio
Journal:  Vet Immunol Immunopathol       Date:  2002-02       Impact factor: 2.046

7.  RNA replication of mouse hepatitis virus takes place at double-membrane vesicles.

Authors:  Rainer Gosert; Amornrat Kanjanahaluethai; Denise Egger; Kurt Bienz; Susan C Baker
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus.

Authors:  Dorothea L Sawicki; Tao Wang; Stanley G Sawicki
Journal:  J Gen Virol       Date:  2001-02       Impact factor: 3.891

9.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

10.  Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors.

Authors:  Daniel N Lewicki; Thomas M Gallagher
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157
View more
  106 in total

1.  Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.

Authors:  Z F Sun; X J Meng
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 2.  Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Authors:  Wenhui Li; Swee-Kee Wong; Fang Li; Jens H Kuhn; I-Chueh Huang; Hyeryun Choe; Michael Farzan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Channel-Inactivating Mutations and Their Revertant Mutants in the Envelope Protein of Infectious Bronchitis Virus.

Authors:  Janet To; Wahyu Surya; To Sing Fung; Yan Li; Carmina Verdià-Bàguena; Maria Queralt-Martin; Vicente M Aguilella; Ding Xiang Liu; Jaume Torres
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

4.  Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.

Authors:  Edward N van den Brink; Jan Ter Meulen; Freek Cox; Mandy A C Jongeneelen; Alexandra Thijsse; Mark Throsby; Wilfred E Marissen; Pauline M L Rood; Alexander B H Bakker; Hans R Gelderblom; Byron E Martina; Albert D M E Osterhaus; Wolfgang Preiser; Hans Wilhelm Doerr; John de Kruif; Jaap Goudsmit
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus.

Authors:  Liqun Lu; Ivanus Manopo; Bernard P Leung; Hiok Hee Chng; Ai Ee Ling; Li Lian Chee; Eng Eong Ooi; Shzu-Wei Chan; Jimmy Kwang
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Authors:  Tae Woo Kim; Jin Hyup Lee; Chien-Fu Hung; Shiwen Peng; Richard Roden; Mei-Cheng Wang; Raphael Viscidi; Ya-Chea Tsai; Liangmei He; Pei-Jer Chen; David A K Boyd; T-C Wu
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 7.  [SARS: a new illness unmasked].

Authors:  A Pareja Bezares; M Torán Mateos
Journal:  Aten Primaria       Date:  2003-11-30       Impact factor: 1.137

8.  Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site.

Authors:  Erik Lontok; Emily Corse; Carolyn E Machamer
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 9.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

10.  Duration of antibody responses after severe acute respiratory syndrome.

Authors:  Li-Ping Wu; Nai-Chang Wang; Yi-Hua Chang; Xiang-Yi Tian; Dan-Yu Na; Li-Yuan Zhang; Lei Zheng; Tao Lan; Lin-Fa Wang; Guo-Dong Liang
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.